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1. Introduction 
Purification of human neurophysin(s) has been 
attempted [l-4]. Several neurophysin components 
have been detected by electrophoresis but because of 
the easy degradation of these proteins [5], the number 
of authentic neurophysins remains to be determined. 
Two components have been purified [2] designated 
neurophysin I and II, according to their electropho- 
retie mobilities. The N-terminal sequence of neuro- 
physin 1 has been established [3,6] but there is no 
structural information about neurophysin Il. 
A classification of neurophysins by the nature of 
residues 2,3,6 and 7 has been suggested [7] and it is 
clear from the results now available, that two families, 
MSEL and VLDV neurophysins, can be distinguished 
on this sequential basis. To now MSEL neurophysins 
have fully been characterized in 5 mammalian species 
(c.f. [S]) and VLDV neurophysins in two species [9]. 
It seems therefore that each mammalian species has 
one neurophysin of each type. From the N-terminal 
sequence of human neurophysin 1 [3,6] we have 
deduced [7] that this neurophysin should belong to 
the VLDV neurophysin family. If so a representative 
of the second type should exist along with the VLDV 
neurophysin. Here we report data showing that a 
second neurophysin, belonging to the MSEl neuro- 
physin family, is present in human pituitary gland. 
2. Materials and methods 
A ‘crude’ neurophysin fraction was prepared from 
acetone-desiccated human posterior pituitaries by the 
Elsevier/North-Holland Biomedical Press 
method in [4]. This material was subjected to contin- 
uous preparative disc electrophoresis in polyacrylamide 
gel [4]. Four components called PG I, PG II, PG III 
and PC IV, following decreasing electrophoretic 
mobilities to the anode, were isolated. Immunological 
tests have revealed that PG I, PG 11 and PG IV show 
great crossreactivity between them but little with 
PG III [4]. Chemical investigations have now been 
performed on PG 11, PG IV and on the ‘crude’ neuro- 
physin fraction. 
Neurophysins were oxidized by performic acid and 
split by trypsin [5]; resulting peptides were separated 
by peptide mapping as in [lo] and characterized by 
amino acid composition [ 1 11. Amino acid sequence was 
determined either by a manual Edman degradation 
[ 121 for the fragments or by the automated method 
in [ 131 in a Socosi model P 110 sequencer for the 
proteins. Phenylthiohydantoin amino acids were iden- 
tified by thin-layer chromatography [14]. 
3. Results 
3.I.PGII 
PG II-1 mg (100 mnol for mol. wt 10 000 
deduced from amino acid composition) after desalting 
by passage through a Sephadex G-25 column, were 
oxidized by performic acid and subjected to trypsin 
hydrolysis. Tryptic fragments (8) were separated by 
peptide mapping (-15-20 nmol of each peptide were 
recovered) and analyzed. Peptide maps obtained for 
MSEL neurophysins of other mammalian species were 
compared [5,8]. Three peptides Tl, T2 and T3 had 
the same relative positions on the map and the same 
amino acid compositions (table 1) as those found for 
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the N-terminal peptides Tl, T2 and T3 of MSEL 
neurophysins [5]; it can therefore be assumed that 
the N-terminal sequence of PC II is identical with the 
N-terminal sequence found for the MSEL neurophysin 
family [8]. 
3.2. PG IV 
PC IV -0.8 mg (80 nmol) was subjected to oxida- 
tion, trypsin hydrolysis and peptide mapping (-5 nmol 
of each peptide were recovered). The map was very 
similar to that given by PC II except that there is an 
additional peptide. Three peptides having the same 
relative positions and the same amino acid composi- 
tions as Tl , T2 and T3 of PG II were identified. It 
can be inferred that PG IV has the same N-terminal 
sequence as PG II. However, the additional peptide 
occupies the position and has the amino acid compo- 
sition (Arg, Ala) of the C-terminal fragment found in 
pig, horse and whale MSEL neurophysins [8]. PG IV 
seems to be the intact MSEL neurophysin and PG II a 
C-terminal truncated form. 
3.3. Unfractionated neurophysins 
After desalting 3 mg (-300 nmol) was subjected 
to performic acid oxidation, tryptic hydrolysis and 
resulting fragments were separated by peptide 
mapping. A fragment located on the map as peptide 
Tl of PG II and PG IV was analyzed and completely 
sequenced by manual Edman procedure (table 1). It 
shows the N-terminal sequence of a typical MSEL 
neurophysin. Another fragment located on the map 
as peptide T2 of PG II and PG IV was also analyzed and 
partially sequenced (table 1). Its N-terminal sequence 
Gln-CySO,H-Leu-Pro agrees with the N-terminal 
sequence of a peptide T2 from a typical MSEL neuro. 
physin. 
Automated degradation was done on 2.3 mg 
(230 nmol) of the ‘unfractionated’ neurophysin. 
Results are indicated in table 1. It is clear that this 
fraction is a mixture of two neurophysins which have 
identical residues in positions 1,4,5,8, 10 and 11 
but different residues in positions 2,3,6,7 and 9. 
The N-terminal sequence of human neurophysin I is 
known [3,6];because this protein has alanine, proline, 
aspartic acid, valine and lysine, respectively, in posi- 
tions 2, 3,6,7 and 9, by difference the N-terminal 
sequence Ala-Met-Ser-Asp-Leu-Glu-Leu-Arg- 
Gln-Cys-Leu can be assigned to the second neuro- 
physin. This agrees with the sequence deduced from 
peptides Tl and T2. 
The results as a whole indicate that a neurophysin 
belonging to the MSEL neurophysin family is present 
in human pituitary gland. We assume that PG IV is 
the intact protein and PG II a C-terminal truncated 
form, in agreement with immunochemical data [4]. 
Such a truncation has been observed for the porcine 
MSEL neurophysin [5]. 
However, the results obtained by automated 
Edman degradation on the unfractionated neuro- 
physins reveal that a second neurophysin having the 
same N-terminal sequence as that found for neuro- 
physin I [3,6] is also present. As suggested [7], 
neurophysin I probably belongs to the VLDV neuro- 
physin lineage, due to the nature of residues 6, 7 and 
9. The Edman degradation carried out on unfraction- 
ated neurophysins does not indicate another type of 
neurophysin so that 2 of the 4 components isolated 
by electrophoresis are probably derivatives or 
C-truncated forms of MSEL or VLDV neurophysins. 
The two types of neurophysins have been fully 
characterized in ox and pig [8,9] and we can assume 
that they will be present in most mammalian species. 
There is indirect evidence for a specific biological 
relationship between vasopressin and oxytocin with 
MSEL and VLDV neurophysin, respectively [ 151. 
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